SALAS | MALLEABLE SURGICAL RETRACTOR FOR COMPLETE EXPOSURE OF MITRAL VALVE

Summary
Heart valves play a key role in the way blood flow, opening and closing with each heartbeat. Almost all interventions in cardiac surgery are performed to repair or replace the mitral, aortic or tricuspid valve. In specific case of mitral valve surgery, good exposure of mitral valve and its ring is essential for the surgeon
Conventional mitral valve surgery is performed opening the sternum (20-25cm) with a retractor and then surgical operation is carried out. The use of minimally invasive (MIS) surgery allows decrease of recovery time, decrease of surgical trauma, reduction of pain improving patient satisfaction and reducing hospital resource utilization. All this advantages, make that nowadays half of mitral surgery operations are made in developed countries following MIS techniques. Main drawback of MIS surgery is that operation areas exposure is limited which makes surgeons work harder than doing it in open surgery. Better exposure translates into better surgical results, optimal stability of the surgery and optimal long-time clinical results. In Minimall invasive mitral surgery, only an anterior traction retractor is used but the exposure that allows to the surgeon is limited.
Due to aging of population and development of emerging countries, mitral valve surgical procedures are growing market worldwide expecting to double its actual size for 2030.
In this scenario, ANSABERE in collaboration with Dr. Anas Sarraj (surgeon of Hospital La Princesa in Madrid and associate professor of Autonomous University of Madrid) has developed an innovative device for both mitral conventional and MIS surgery, called SALAS, that provide better and complete exposition of the mitral valve and its ring from inside the left atrium. The instrument allows to surgeon to adjust and adapt the working area due to the use of the lateral flap and the malleability of the arms of the invention.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/744712
Start date: 01-01-2017
End date: 30-06-2017
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

Heart valves play a key role in the way blood flow, opening and closing with each heartbeat. Almost all interventions in cardiac surgery are performed to repair or replace the mitral, aortic or tricuspid valve. In specific case of mitral valve surgery, good exposure of mitral valve and its ring is essential for the surgeon
Conventional mitral valve surgery is performed opening the sternum (20-25cm) with a retractor and then surgical operation is carried out. The use of minimally invasive (MIS) surgery allows decrease of recovery time, decrease of surgical trauma, reduction of pain improving patient satisfaction and reducing hospital resource utilization. All this advantages, make that nowadays half of mitral surgery operations are made in developed countries following MIS techniques. Main drawback of MIS surgery is that operation areas exposure is limited which makes surgeons work harder than doing it in open surgery. Better exposure translates into better surgical results, optimal stability of the surgery and optimal long-time clinical results. In Minimall invasive mitral surgery, only an anterior traction retractor is used but the exposure that allows to the surgeon is limited.
Due to aging of population and development of emerging countries, mitral valve surgical procedures are growing market worldwide expecting to double its actual size for 2030.
In this scenario, ANSABERE in collaboration with Dr. Anas Sarraj (surgeon of Hospital La Princesa in Madrid and associate professor of Autonomous University of Madrid) has developed an innovative device for both mitral conventional and MIS surgery, called SALAS, that provide better and complete exposition of the mitral valve and its ring from inside the left atrium. The instrument allows to surgeon to adjust and adapt the working area due to the use of the lateral flap and the malleability of the arms of the invention.

Status

CLOSED

Call topic

SMEInst-05-2016-2017

Update Date

26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.0. Cross-cutting call topics
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector